Pending Government Drug Pricing Will Harm Seniors’ Care And Budgets

Pending Government Drug Pricing Will Harm Seniors’ Care And Budgets

Any day now, the Biden administration will publish the prices it has set for ten drugs covered by Medicare’s Part D prescription drug benefit.

These price controls will provide “meaningful financial relief for millions of people with Medicare,” administration officials say.

Many seniors are about to see just how false that promise is. Millions of beneficiaries won’t see a nickel in relief at the pharmacy counter. In fact, their costs will go up.

Click to read the full article in Forbes.